Abbott to acquire Alere, becoming leader in point of care testing and significantly advancing global diagnostics presence

Abbott gains leadership in the $5.5 billion point of care segment, broadens diagnostics footprint and enhances access to fast-growing diagnostics channels

- Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close
- Acquisition will provide access to new product applications, channels and geographies
- Alere's complementary technologies will help Abbott provide better care for patients by meeting the growing demand for fast, accurate and actionable medical information